GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer

Clinical trial NCT00400517 · COMPLETED

Trial details

NCT number: NCT00400517
Sponsor: The Cleveland Clinic
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2003-03-01
Primary completion: 2008-06-01
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.